NeuroSense Therapeutics reported asset growth of -77.53% for the quarter ended Dec 2025. These growth metrics cover 15 quarters of results from Dec 2021 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||||||||||
| Assets Growth (1y) | 1,367.39% | -32.49% | -62.84% | -31.30% | -41.65% | -58.73% | -72.90% | -76.60% | -81.73% | 43.64% | -8.53% | -77.53% | |||
| Assets Growth (3y) | 59.90% | -26.31% | -47.22% | -48.93% | |||||||||||
| Assets Growth (5y) | 5.70% | ||||||||||||||
| Assets (QoQ) | 25.60% | -20.23% | -19.41% | -16.39% | -30.87% | 47.48% | -31.55% | -40.87% | -54.60% | 27.32% | -46.55% | 364.94% | |||
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 0.00% | 406.87% | -84.44% | 63.00% | 7.89% | 0.00% | -45.92% | -82.96% | -92.77% | -4.66% | -44.87% | -95.09% | |||
| Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) | 71.78% | 69.07% | -46.50% | -63.95% | |||||||||||
| Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) | -24.99% | ||||||||||||||
| Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) | 1,149.64% | -50.21% | 1.43% | -19.68% | -61.64% | 421.63% | -32.87% | -25.55% | -79.25% | 64.35% | -71.52% | 881.98% | |||
| EBIT Growth (1y) | -139.81% | 8.36% | 6.13% | 20.88% | -703.67% | -0.10% | 10.09% | 19.76% | 42.16% | ||||||
| EBIT Growth (3y) | -56.74% | ||||||||||||||
| EBIT (QoQ) | -441.07% | -9.99% | 7.55% | 88.52% | -685.04% | -12.67% | 22.08% | -16.60% | 2.22% | -1.20% | 30.46% | 15.95% | |||
| EBT Growth (1y) | -132.66% | 1.87% | 48.55% | 150.03% | -626.15% | -14.32% | -72.65% | -241.60% | 84.67% | ||||||
| EBT Growth (3y) | -33.21% | ||||||||||||||
| EBT (QoQ) | -154.79% | -27.80% | 12.81% | 46.50% | -64.61% | 32.99% | 184.79% | -876.41% | 74.08% | -1.20% | 30.46% | 15.95% | |||
| EPS (Basic) Growth (1y) | -117.73% | 46.75% | 72.08% | 127.15% | -512.45% | 3.58% | -45.62% | -219.43% | 88.76% | ||||||
| EPS (Basic) Growth (3y) | -28.50% | ||||||||||||||
| EPS (Basic) (QoQ) | -154.79% | -27.80% | 12.81% | 70.97% | -64.61% | 32.99% | 184.79% | -754.85% | 74.08% | -1.20% | 30.46% | 38.37% | |||
| EPS (Diluted) Growth (1y) | -117.73% | 46.75% | 72.08% | 127.15% | -512.45% | 3.58% | -45.62% | -219.43% | 88.76% | ||||||
| EPS (Diluted) Growth (3y) | -28.50% | ||||||||||||||
| EPS (Diluted) (QoQ) | -154.79% | -27.80% | 12.81% | 70.97% | -64.61% | 32.99% | 184.79% | -754.85% | 74.08% | -1.20% | 30.46% | 38.37% | |||
| Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) | -386.36% | -93.20% | -98.26% | -34.07% | 70.65% | ||||||||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | 17,672.30% | -27.72% | 223.58% | -101.18% | 345.64% | -81.48% | 12,146.87% | -100.53% | |||||||
| Net Income Growth (1y) | -132.66% | 1.87% | 48.55% | 150.03% | -626.15% | -14.32% | -72.65% | -241.60% | 84.67% | ||||||
| Net Income Growth (3y) | -33.21% | ||||||||||||||
| Net Income (QoQ) | -154.79% | -27.80% | 12.81% | 46.50% | -64.61% | 32.99% | 184.79% | -876.41% | 74.08% | -1.20% | 30.46% | 15.95% | |||
| Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) | -132.66% | 1.87% | 48.55% | 150.03% | -626.15% | -14.32% | -72.65% | -241.60% | 84.67% | ||||||
| Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) | -33.21% | ||||||||||||||
| Net Income towards Common Stockholders (QoQ)Net Income (QoQ) | -154.79% | -27.80% | 12.81% | 46.50% | -64.61% | 32.99% | 184.79% | -876.41% | 74.08% | -1.20% | 30.46% | 15.95% | |||
| Operating Income Growth (1y)Op. Inc Growth (1y) | -139.81% | 8.36% | 6.13% | 20.88% | -703.67% | -0.10% | 10.09% | 19.76% | 42.16% | ||||||
| Operating Income Growth (3y)Op. Inc Growth (3y) | -56.74% | ||||||||||||||
| Operating Income (QoQ)Op. Inc (QoQ) | -441.07% | -9.99% | 7.55% | 88.52% | -685.04% | -12.67% | 22.08% | -16.60% | 2.22% | -1.20% | 30.46% | 15.95% | |||
| Profit After Tax Growth (1y)PAT Growth (1y) | -118.18% | -7.70% | -140.92% | 97.73% | -144.78% | -84.82% | 419.94% | -4,091.43% | 43.49% | ||||||
| Profit After Tax Growth (3y)PAT Growth (3y) | -31.07% | ||||||||||||||
| Profit After Tax (QoQ)PAT (QoQ) | -137.92% | 428.21% | -272.66% | 91.54% | -124.58% | -24.69% | 90.40% | -810.57% | -69.56% | 315.86% | -225.76% | 87.72% | |||
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | 46.15% | 1,668.42% | -3.65% | -12.03% | -16.86% | -19.94% | -19.87% | -27.69% | -29.18% | -35.69% | -42.34% | 44.51% | |||
| Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) | 174.54% | 108.82% | -28.42% | -9.38% | |||||||||||
| Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) | 80.63% | ||||||||||||||
| Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) | 1,631.58% | 6.08% | -3.15% | -0.59% | -5.65% | -3.15% | -8.47% | -4.27% | -5.58% | -12.60% | -10.36% | -13.07% | |||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -2711.00 | -21130.00 | -47742.00 | -84354.00 | -132600.00 | -1932.00 | |||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -8518.00 | -3672.00 | 2,694.00 | 6,785.00 | -26937.00 | -30285.00 | -33917.00 | -41461.00 | 103,731.00 | ||||||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -14866.00 | -130142.00 | 76,022.00 | 90,790.00 | 71,754.00 | 20,044.00 | |||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -5971.00 | -6081.00 | -6252.00 | 3,438.00 | -121247.00 | 200,084.00 | 8,515.00 | -15598.00 | -172958.00 | ||||||
| Share-based Compensation Growth (1y)Stock Comp. Growth (1y) | 34.69% |
Pull NeuroSense Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NRSN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NRSN", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=NRSN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();